This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

IMCD-Shanghai Sanrise among deals published in China for fast-track review

( February 10, 2023, 09:52 GMT | Official Statement) -- MLex Summary: China’s State Administration for Market Regulation has published four transactions for a fast-track review. The deals include specialty-chemicals distributor IMCD (China)’s buy of a 70 percent stake in Shanghai Sanrise Industries & Development; and Mitsubishi Gas Chemical’s purchase of a 25 percent stake in Mitsubishi Engineering-Plastics. The period for public comment runs through Feb. 18.The list of deals follows and the notification forms are attached:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login